TrialAntimicrobial agents and chemotherapy2020

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects.

Jason D Lickliter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.